{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:39:23Z","timestamp":1792269563556,"version":"4.4.0"},"reference-count":35,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Mundipharma Polska Sp. z o.o.,"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr. Rep.","Pediatric Reports"],"abstract":"<jats:p>Central nervous system (CNS) relapse remains a major cause of treatment failure in pediatric acute lymphoblastic leukemia (ALL). Repeated isolated CNS relapse is particularly rare and associated with poor prognosis, while optimal therapeutic strategies remain insufficiently defined. Intensified CNS-directed therapy may improve disease control but is also associated with substantial long-term neurotoxicity and survivorship burden. We present the case of a boy with favorable-risk B-cell ALL who developed two isolated CNS relapses despite a good initial response to frontline therapy and absence of classical CNS relapse risk factors. The second relapse was associated with extensive meningeal involvement and optic nerve infiltration. The patient underwent intensive multimodal CNS-directed therapy, including repeated intrathecal chemotherapy, liposomal cytarabine administered according to the IntReALL 2010 protocol, cranial irradiation, and allogeneic hematopoietic stem cell transplantation (alloHSCT) from a matched sibling donor. Durable long-term remission was achieved despite the extremely unfavorable prognosis that is associated with a second isolated CNS relapse. A twenty-year follow-up extending into early adulthood revealed substantial late complications, including epilepsy, transient ischemic attack, optic nerve injury, endocrinopathies, obesity, secondary thyroid malignancy, neurocognitive difficulties, and depression requiring long-term psychiatric and psychological support. The present case illustrates the complex balance between effective CNS disease control and cumulative treatment-related neurotoxicity in pediatric ALL survivors. It also highlights the cumulative CNS injury and long-term survivorship burden that is associated with repeated CNS relapse and multimodal CNS-directed therapy.<\/jats:p>","DOI":"10.3390\/pediatric18050121","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:03:17Z","timestamp":1789632197000},"page":"121","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Long-Term Sequelae in Patients Treated for Recurrent CNS Relapses of Pediatric B-Cell Acute Lymphoblastic Leukemia: 20-Year Follow-Up, Neurological Consequences, and Survivorship Burden\u2014A Case Report and Literature Review"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7266-7694","authenticated-orcid":false,"given":"Maciej","family":"Nied\u017awiecki","sequence":"first","affiliation":[{"name":"Department of Paediatrics, Haematology and Oncology, Medical University of Gda\u0144sk, Sk\u0142odowskiej-Curie 3a, 80-210 Gdansk, Poland"},{"name":"Fahrenheit Union of Universities, Gda\u0144sk Zwyci\u0119stwa Ave. 27, 80-219 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8760-0775","authenticated-orcid":false,"given":"Monika","family":"Lejman","sequence":"additional","affiliation":[{"name":"Independent Laboratory of Genetic Diagnostics, Medical University of Lublin, A. G\u0119bali 6, 20-093 Lublin, Poland"},{"name":"Department of Genetic Diagnostics, Children\u2019s University Hospital, A. G\u0119bali 6, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8052-4129","authenticated-orcid":false,"given":"Mieszko","family":"Czapli\u0144ski","sequence":"additional","affiliation":[{"name":"Fahrenheit Union of Universities, Gda\u0144sk Zwyci\u0119stwa Ave. 27, 80-219 Gdansk, Poland"},{"name":"University Clinical Centre, Medical University of Gda\u0144sk, D\u0119binki 7, 80-952 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4232-6557","authenticated-orcid":false,"given":"Janusz","family":"Springer","sequence":"additional","affiliation":[{"name":"Fahrenheit Union of Universities, Gda\u0144sk Zwyci\u0119stwa Ave. 27, 80-219 Gdansk, Poland"},{"name":"Division of Preventive Medicine & Education, Medical University of Gdansk, Sk\u0142odowskiej-Curie 3a, 80-210 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6418-0360","authenticated-orcid":false,"given":"Anna","family":"Synakiewicz","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Haematology and Oncology, Medical University of Gda\u0144sk, Sk\u0142odowskiej-Curie 3a, 80-210 Gdansk, Poland"},{"name":"Fahrenheit Union of Universities, Gda\u0144sk Zwyci\u0119stwa Ave. 27, 80-219 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5288-0586","authenticated-orcid":false,"given":"Eliza","family":"Wasilewska","sequence":"additional","affiliation":[{"name":"Fahrenheit Union of Universities, Gda\u0144sk Zwyci\u0119stwa Ave. 27, 80-219 Gdansk, Poland"},{"name":"Department of Allergology, Medical University of Gda\u0144sk, Sk\u0142odowskiej-Curie 3a, 80-210 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"ref_1","unstructured":"Nadziei, P. (2026, July 20). Nawr\u00f3t Ostrej Bia\u0142Aczki Limfoblastycznej (ALL) u Dzieci\u2014Post\u0119powanie i Dost\u0119Pne Opcje Terapeutyczne. Available online: https:\/\/przyladeknadziei.pl\/nawrot-ostrej-bialaczki-limfoblastycznej-all-u-dzieci-postepowanie-i-dostepne-opcje-terapeutyczne\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1200\/JCO.2005.03.3373","article-title":"Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: A Pediatric Oncology Group study","volume":"24","author":"Barredo","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1182\/asheducation-2006.1.142","article-title":"Central nervous system disease in acute lymphoblastic leukemia: Prophylaxis and treatment","volume":"2006","author":"Pui","year":"2006","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1046\/j.1365-2141.2003.04158.x","article-title":"Prognostic factors and outcome for children after second central nervous system relapse of acute lymphoblastic leukaemia","volume":"120","author":"Morris","year":"2003","journal-title":"Br. J. Haematol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.leu.2405037","article-title":"Outcomes after HLA-matched sibling transplantation or chemotherapy in children with acute lymphoblastic leukemia in a second remission after an isolated central nervous system relapse: A collaborative study of the Children\u2019s Oncology Group and the Center for International Blood and Marrow Transplant Research","volume":"22","author":"Eapen","year":"2008","journal-title":"Leukemia"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0140-6736(98)11079-6","article-title":"High incidence of secondary brain tumours after radiotherapy and antimetabolites","volume":"354","author":"Relling","year":"1999","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00277-008-0546-0","article-title":"Neurological complications after intrathecal liposomal cytarabine application in patients after allogeneic haematopoietic stem cell transplantation","volume":"87","author":"Hilgendorf","year":"2008","journal-title":"Ann. Hematol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00277-008-0521-9","article-title":"Neuroophthalmological side effects following intrathecal administration of liposomal cytarabine for central nervous system prophylaxis in three adolescents with acute myeloid leukaemia","volume":"87","author":"Sommer","year":"2008","journal-title":"Ann. Hematol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1517\/14656566.9.2.301","article-title":"Liposomal cytarabine for leukemic and lymphomatous meningitis: Recent developments","volume":"9","author":"Benesch","year":"2008","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/MPH.0000000000000642","article-title":"Efficacy and toxicity of intrathecal liposomal cytarabine in first-line therapy of childhood acute lymphoblastic leukemia","volume":"38","author":"Levinsen","year":"2016","journal-title":"J. Pediatr. Hematol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.bbmt.2008.03.011","article-title":"Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system","volume":"14","author":"Thomas","year":"2008","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1200\/JCO.2013.48.6522","article-title":"Intensive chemotherapy for childhood acute lymphoblastic leukemia: Results of the randomized intercontinental trial ALL IC-BFM 2002","volume":"32","author":"Stary","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1182\/blood.V91.5.1716.1716_1716_1722","article-title":"TEL-AML1 Fusion Transcript in Relapsed Childhood Acute Lymphoblastic Leukemia","volume":"91","author":"Seeger","year":"1998","journal-title":"Blood"},{"key":"ref_14","unstructured":"von Stackelberg, A., Qi, C., Saha, V., Locatelli, F., Moschandreas, J., and Love, S. (2017, January 5\u20138). IntReALL SR 2010: An international randomised phase III study for the treatment of standard risk childhood relapsed acute lymphoblastic leukaemia. Proceedings of the National Cancer Research Institute Cancer Conference, Liverpool, UK."},{"key":"ref_15","first-page":"277","article-title":"Effect of initial central nervous system (CNS) status on event-free survival (EFS) in children and adolescents with acute lymphoblastic leukemia (ALL) [Abstract SL035]","volume":"39","author":"Nachman","year":"2002","journal-title":"Med. Pediatr. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1200\/JCO.1994.12.12.2594","article-title":"Low numbers of CSF blasts at diagnosis do not predict the development of CNS leukemia in children with intermediate-risk acute lymphoblastic leukemia: A Children\u2019s Cancer Group report","volume":"12","author":"Gilchrist","year":"1994","journal-title":"J. Clin. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1200\/JCO.2005.03.9727","article-title":"Prognostic significance of blasts in the cerebrospinal fluid without pleiocytosis or a traumatic lumbar puncture in children with acute lymphoblastic leukemia: The experience of the Dutch Childhood Oncology Group","volume":"24","author":"Kamps","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1200\/JCO.2003.04.096","article-title":"Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: Significance of low leukocyte counts with blasts or traumatic lumbar puncture","volume":"21","author":"Zimmermann","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood-2005-12-011809","article-title":"Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared to intrathecal methotrexate: Results of the Children\u2019s Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia","volume":"108","author":"Matloub","year":"2006","journal-title":"Blood"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1182\/blood-2004-11-4544","article-title":"Pharmacogenetics of outcome in children with acute lymphoblastic leukemia","volume":"105","author":"Rocha","year":"2005","journal-title":"Blood"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1200\/JCO.2004.01.046","article-title":"Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis","volume":"22","author":"Bomgaars","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1259\/0007-1285-60-713-469","article-title":"The cribriform plate: A sanctuary site for meningeal leukaemia","volume":"60","author":"Williams","year":"1987","journal-title":"Br. J. Radiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1182\/blood.V92.2.411","article-title":"Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia","volume":"92","author":"Pui","year":"1998","journal-title":"Blood"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/cyto.b.21029","article-title":"Flow cytometric detection of liposomal cytarabine in cerebrospinal fluid of patients treated with intrathecal chemotherapy","volume":"82B","author":"Stacchini","year":"2012","journal-title":"Cytom. Part B Clin. Cytom."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3109\/10428194.2014.927456","article-title":"Toxicity and efficacy of intrathecal liposomal cytarabine in children with leukemia\/lymphoma relapsing in the central nervous system: A retrospective multicenter study","volume":"56","author":"Parasole","year":"2015","journal-title":"Leuk. Lymphoma"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1097\/MPH.0b013e3181ec0c25","article-title":"Intrathecal liposomal cytarabine in relapsed or refractory infant and pediatric leukemias: The Children\u2019s Hospital of Philadelphia experience and review of the literature","volume":"32","author":"Seif","year":"2010","journal-title":"J. Pediatr. Hematol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1080\/10428190802216749","article-title":"Efficacy and safety of intrathecal liposomal cytarabine for the treatment of meningeal relapse in acute lymphoblastic leukemia: Experience of two pediatric institutions","volume":"49","author":"Parasole","year":"2008","journal-title":"Leuk. Lymphoma"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/MPH.0b013e318041f112","article-title":"Feasibility and toxicity of intrathecal liposomal cytarabine in 5 children and young adults with refractory neoplastic meningitis","volume":"29","author":"Benesch","year":"2007","journal-title":"J. Pediatr. Hematol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1200\/JCO.2003.10.032","article-title":"Toward optimal central nervous system-directed treatment in childhood acute lymphoblastic leukemia","volume":"21","author":"Pui","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1200\/JCO.23.02238","article-title":"Genomic determinants of outcome in acute lymphoblastic leukemia","volume":"42","author":"Chang","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10555-020-09848-z","article-title":"Involvement of the central nervous system in acute lymphoblastic leukemia: Opinions on molecular mechanisms and clinical implications based on recent data","volume":"39","author":"Lenk","year":"2020","journal-title":"Cancer Metastasis Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1182\/blood.2023023336","article-title":"Germline genetic NBN variation and predisposition to B-cell acute lymphoblastic leukemia in children","volume":"143","author":"Escherich","year":"2024","journal-title":"Blood"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00280-024-04694-0","article-title":"Systematic review: Genetic polymorphisms in the pharmacokinetics of high-dose methotrexate in pediatric acute lymphoblastic leukemia patients","volume":"94","author":"Rahmayanti","year":"2024","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S1470-2045(25)00157-3","article-title":"Contributions of cancer treatment and genetic predisposition to risk of subsequent neoplasms in long-term survivors of childhood cancer: A report from the St Jude Lifetime Cohort and the Childhood Cancer Survivor Study","volume":"26","author":"Neupane","year":"2025","journal-title":"Lancet Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e513","DOI":"10.1016\/S2352-3026(21)00136-8","article-title":"Severe toxicity free survival: Physician-derived definitions of unacceptable long-term toxicities following acute lymphocytic leukaemia","volume":"8","author":"Schmiegelow","year":"2021","journal-title":"Lancet Haematol."}],"container-title":["Pediatric Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2036-7503\/18\/5\/121\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:13:05Z","timestamp":1789636385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2036-7503\/18\/5\/121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["pediatric18050121"],"URL":"https:\/\/doi.org\/10.3390\/pediatric18050121","relation":{},"ISSN":["2036-7503"],"issn-type":[{"value":"2036-7503","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]}}}